PAREXEL International Corporation (PRXL)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
71.11+0.89 (+1.27%)
At close: 4:00 PM EDT
People also watch:
ICLRCRLTECHUTHRPRGO
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open69.99
Prev Close70.22
Bid0.00 x
Ask70.95 x 100
Day's Range69.99 - 71.13
52wk Range56.00 - 73.62
1y Target EstN/A
Market Cap3.76B
P/E Ratio (ttm)24.61
Beta0.47
Volume310,452
Avg Vol (3m)390,863
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube5 days ago

    ETF’s with exposure to PAREXEL International Corp. : August 26, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to PAREXEL International Corp. Here are 5 ETF’s with the largest exposure to PRXL-US. Comparing the performance and risk of PAREXEL International Corp. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • PAREXEL International Corp. :PRXL-US: Earnings Analysis: 2016 By the Numbers : August 22, 2016
    Capital Cube9 days ago

    PAREXEL International Corp. :PRXL-US: Earnings Analysis: 2016 By the Numbers : August 22, 2016

    Categories: Yahoo Finance Get free summary analysis PAREXEL International Corp. reports financial results for the year ended June 30, 2016. We analyze the earnings along side the following peers of PAREXEL International Corp. – ICON Plc, Charles River Laboratories International, Inc., Quintiles Transnational Holdings, Inc., Medidata Solutions, Inc., Bioanalytical Systems, Inc. and SCYNEXIS, Inc. (ICLR-US, CRL-US, Q-US, MDSO-US, ... Read more (Read more...)

  • PAREXEL’s Head of BioPharm Unit Named to the 2016 PharmaVOICE 100
    Business Wire16 days ago

    PAREXEL’s Head of BioPharm Unit Named to the 2016 PharmaVOICE 100

    PAREXEL International Corporation , a leading global biopharmaceutical services provider, today announced that PharmaVOICE magazine selected Ubavka DeNoble, MD, Corporate Vice President, as one of the 100 most inspiring people in the life sciences industry.